Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson's disease: An 8-year longitudinal study

CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories

(2020) Stefanie Lerche et al.   MOVEMENT DISORDERS

Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson's disease

(2020) Frederic Sampedro et al.   PARKINSONISM & RELATED DISORDERS

Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease

(2020) Adeline Su Lyn Ng et al.   Molecular Neurodegeneration

NfL as a biomarker for neurodegeneration and survival in Parkinson disease

(2020) David Bäckström et al.   NEUROLOGY

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

(2019) Tainá M. Marques et al.   NEUROLOGY

Parkinson's disease motor subtype changes during 20 years of follow-up

(2019) Robert S. Eisinger et al.   PARKINSONISM & RELATED DISORDERS

Blood NfL

(2019) Chin-Hsien Lin et al.   NEUROLOGY

Neurofilaments as biomarkers in neurological disorders

(2018) Michael Khalil et al.   Nature Reviews Neurology

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

(2018) Yung-Shuan Lin et al.   Scientific Reports

11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study

(2017) Weihua Li et al.   MOVEMENT DISORDERS

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Postural instability and gait are associated with severity and prognosis of Parkinson disease

(2016) Jorine F. van der Heeden et al.   NEUROLOGY

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?

(2016) Tanya Simuni et al.   PARKINSONISM & RELATED DISORDERS

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

(2013) Glenn T. Stebbins et al.   MOVEMENT DISORDERS

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Differences in nigro-striatal impairment in clinical variants of early Parkinson’s disease: evidence from a FP-CIT SPECT study

(2009) C. Rossi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls

(2008) S. A. Eshuis et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING